Showing results (1321-1330 of 1,344) with videos related to

Sort By:
Pageof 135
The Pharmacogenomics Journal|October 6, 2018
Pharmacogenomics in epithelial ovarian cancer first-line treatment outcome: validation of GWAS-associated NRG3 rs1649942 and BRE rs7572644 variants in an independent cohortRicardo Pinto, Joana Assis, Augusto Nogueira, et al.
The Pharmacogenomics Journal|April 24, 2022
Whole-genome sequencing analysis of clozapine-induced myocarditisAnkita Narang, Paul Lacaze, Kathlyn J Ronaldson, et al.
The Pharmacogenomics Journal|August 27, 2020
Pediatric pharmacogenomics: challenges and opportunities: on behalf of the Sanford Children's Genomic Medicine ConsortiumDavid Gregornik, Daria Salyakina, Marilyn Brown, et al.
The Pharmacogenomics Journal|April 27, 2023
Polygenic risk scores analyses of psychiatric and metabolic traits with antipsychotic-induced weight gain in schizophrenia: an exploratory studyKazunari Yoshida, Victoria S Marshe, Samar S M Elsheikh, et al.
The Pharmacogenomics Journal|April 7, 2021
Genetic variants associated with cardiometabolic abnormalities during treatment with selective serotonin reuptake inhibitors: a genome-wide association studyKatrine K Fjukstad, Lavinia Athanasiu, Shahram Bahrami, et al.
The Pharmacogenomics Journal|January 22, 2014
Copy number variants and therapeutic response to antidepressant medication in major depressive disorderK E Tansey, J J H Rucker, D H Kavanagh, et al.
The Pharmacogenomics Journal|October 17, 2012
Impact of ABCC2 polymorphisms on high-dose methotrexate pharmacokinetics in patients with lymphoid malignancyN Simon, A Marsot, E Villard, et al.
The Pharmacogenomics Journal|October 10, 2012
Pharmacogenomics of phase II metabolizing enzymes and drug transporters: clinical implicationsE Ch Yiannakopoulou
The Pharmacogenomics Journal|October 24, 2012
Pharmacogenetic and pharmacokinetic aspects of CYP3A induction by efavirenz in HIV patientsA Habtewold, W Amogne, E Makonnen, et al.
The Pharmacogenomics Journal|November 12, 2025
Comparative analysis of point-of-care bedside cyp2c19-testing guided anti-platelet therapy versus conventional therapies for cardiovascular diseases: a systematic review and meta-analysisMohammed Khattab, Mohamed Baguneid, George P Patrinos, et al.
Pageof 135